Lupin informs about press release

24 Mar 2022 Evaluate
Lupin has informed that it enclosed press release titled, ‘Lupin Receives Approval from US FDA for Sildenafil for Oral Suspension’.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2184.00 0.00 (0.00%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.